Literature DB >> 10729842

Clinical feasibility of low energy internal atrial cardioversion with a three-electrode configuration in patients with unsuccessful conventional configurations.

G Benedini1, A Gardini, T Toselli, G Antonioli, G Guardigli, G Saccomanno, M Marini.   

Abstract

Low energy internal cardioversion is a safe and highly effective method for atrial fibrillation termination. We will describe 6 patients in whom the conventional 2-electrode systems with the defibrillation leads positioned in the right atrium and in the coronary sinus or left pulmonary artery failed to terminate the arrhythmia despite the use of maximal available energies. A 3-electrode configuration including right atrium, coronary sinus and left pulmonary artery was used in order to encompass as much atrial mass as possible between the cathode and the anode. The atrial fibrillation was successfully interrupted in 4 out of 6 patients. The creation of a 3-electrode configuration may be a further technical expedient in order to increase the success rate of internal cardioversion when usual manoeuvres like lead repositioning, reversion of polarity, or addition of antiarrhythmic drugs are ineffective.

Entities:  

Mesh:

Year:  2000        PMID: 10729842     DOI: 10.1023/a:1009830032399

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  20 in total

1.  Low energy intracardiac cardioversion of persistent atrial fibrillation.

Authors:  M Santini; C Pandozi; S Toscano; A Castro; G Altamura; A P Jesi; G Gentilucci; M Villani; M C Scianaro
Journal:  Pacing Clin Electrophysiol       Date:  1998-12       Impact factor: 1.976

2.  Electrical cardioversion after amiodarone administration.

Authors:  J Sagristà-Sauleda; G Permanyer-Miralda; J Soler-Soler
Journal:  Am Heart J       Date:  1992-06       Impact factor: 4.749

3.  Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation.

Authors:  E Alt; C Schmitt; R Ammer; M Coenen; P Fotuhi; M Karch; R Blasini
Journal:  Pacing Clin Electrophysiol       Date:  1994-05       Impact factor: 1.976

4.  Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation.

Authors:  C Schmitt; E Alt; A Plewan; R Ammer; M Leibig; M Karch; A Schömig
Journal:  J Am Coll Cardiol       Date:  1996-10       Impact factor: 24.094

5.  A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion.

Authors:  E Alt; R Ammer; C Schmitt; F Evans; G Lehmann; J Pasquantonio; A Schömig
Journal:  Eur Heart J       Date:  1997-11       Impact factor: 29.983

6.  Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.

Authors:  L Bianconi; M Mennuni; V Lukic; A Castro; M Chieffi; M Santini
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

7.  Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator.

Authors:  T Guarnieri; J H Levine; E P Veltri; L S Griffith; L Watkins; J Juanteguy; M M Mower; M Mirowski
Journal:  Am J Cardiol       Date:  1987-11-01       Impact factor: 2.778

8.  Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation.

Authors:  S Lévy; P Ricard; C P Lau; N S Lok; A J Camm; F D Murgatroyd; L J Jordaens; L J Kappenberger; P Brugada; K L Ripley
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

9.  Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system.

Authors:  N S Lok; C P Lau; H F Tse; G M Ayers
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

10.  Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.

Authors:  J Wang; G W Bourne; Z Wang; C Villemaire; M Talajic; S Nattel
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.